IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success
- NCT ID
- NCT07494838
- Registry status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Lucas R. Cusumano, MD
- Conditions
- Knee Discomfort, Knee Osteoarthritis, Knee Pain Chronic, Knee Swelling Pain
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Enrollment: 25 participants (Estimated).
What is being studied
- Device: Embolization
- Intervention: Embolization, Therapeutic
- Intervention: Hemostatic Techniques
- Intervention: Therapeutic Occlusion
- Intervention: Therapeutics
Who may be eligible
- Ages
- 40 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* Provided informed consent
* Age ≥ 40 years
* Ineligibility for or refusal of surgical management
* Moderate-severe knee pain as determined by visual analog scale \> 5 out of 10
* Osteoarthritis based on X-ray. Kellgren-Lawrence score \> 2 based on radiograph completed within 3 months of procedure date
* Resistant/failed some form of conservative treatment (e.g. NSAIDS/physical therapy/steroid joint injection/hyaluronic acid joint injection) for at least 3 months
* Able to comply with all treatments and protocol follow-up visits
Exclusion Criteria:
* Mild knee pain as determined by visual analog scale \< 5 out of 10
* OA on knee radiograph resulting in greater than 20 degree varus or valgus angulation
* Moderate loss of kidney function, define as estimated glomerular filtration rate of less than 45 mL/min.
* Significant arterial atherosclerosis that would limit selective angiography
* History of fibromyalgia, autoimmune, or inflammatory disorder
* History of any lumbar spine surgery, spine injections, or radicular pain in the extremity believed to originate from the spine
* Allergy to iodinated contrast agents
* Active infection or malignancy
* Recent (within 12 months) or active cigarette use
* Prior total or partial knee replacement in the subject knee
* Active pregnancy
* Uncorrectable bleeding diathesis
* Presence of pacemakers, aneurysm clips, neurostimulators, or any other metal implant not compatible with PET/MRI
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: United States
- California, United States: 1
Sample of listed locations
- University of California, Los Angeles — Los Angeles, California, 90095, United States — Site recruitment status not specified in the registry data
Study details
- Start date
- December 30, 2026
- Primary completion date
- June 30, 2027
- Completion date
- June 30, 2027
- First posted
- March 27, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07494838
- Registry last updated
- September 21, 2026
- QualifiedStudies registry data refreshed
- October 5, 2026
- QualifiedStudies record fetched
- October 5, 2026
View NCT07494838 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Chronic Pain studies | Knee Pain studies | Clinical trial FAQ